Background
PsA, psoriatic arthritis, PsA., enthesitis
DISEASE, PSORIATIC ARTHRITIS, ENTHESITIS
Tofacitinib is an oral Janus kinase inhibitor for the treatment of psoriatic arthritis (PsA). This post hoc analysis assessed tofacitinib efficacy on enthesitis by baseline location and severity, and impact on disease activity and patient-reported outcomes (PROs), in patients with PsA.